Suppr超能文献

由不同的信使核糖核酸编码的B1和B2缓激肽受体。

B1 and B2 bradykinin receptors encoded by distinct mRNAs.

作者信息

Webb M, McIntyre P, Phillips E

机构信息

Sandoz Institute for Medical Research, London, England, U.K.

出版信息

J Neurochem. 1994 Apr;62(4):1247-53. doi: 10.1046/j.1471-4159.1994.62041247.x.

Abstract

Bradykinin receptors have been subdivided into at least two major pharmacological subtypes, B1 and B2. The cDNAs encoding functional B2 receptors have recently been cloned, but no molecular information exists at present on the B1 receptor. In this article, we describe experiments examining the possible relationship between the mRNAs encoding the B1 and B2 types of receptor. We showed previously that the human fibroblast cell line WI38 expresses both B1 and B2 receptors. In this report, we describe oocyte expression experiments showing that the B1 receptor in WI38 human fibroblast cells is encoded by a distinct mRNA approximately 2 kb shorter than that encoding the B2 receptor. We have used an antisense approach in conjunction with the oocyte expression system to demonstrate that the two messages differ in sequence at several locations throughout the length of the B2 sequence. Taken together with the mixed pharmacology exhibited in some expression systems by the cloned mouse receptor, the data indicate that B1-type pharmacology may arise from two independent molecular mechanisms.

摘要

缓激肽受体已被细分为至少两种主要的药理学亚型,即B1和B2。编码功能性B2受体的cDNA最近已被克隆,但目前关于B1受体尚无分子信息。在本文中,我们描述了研究编码B1和B2型受体的mRNA之间可能关系的实验。我们之前表明,人成纤维细胞系WI38同时表达B1和B2受体。在本报告中,我们描述了卵母细胞表达实验,结果表明WI38人成纤维细胞中的B1受体由一种独特的mRNA编码,该mRNA比编码B2受体的mRNA短约2 kb。我们结合卵母细胞表达系统使用了反义方法,以证明这两种信使RNA在B2序列全长的几个位置上序列不同。结合克隆的小鼠受体在一些表达系统中表现出的混合药理学特性,这些数据表明B1型药理学可能源于两种独立的分子机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验